EP2961831
SAMSETNINGAR OG AÐFERÐIR TIL ÓNÆMISMEÐFERÐAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.2.2014EP published:
10.6.2020EP application number:
14756894.3
EP translation filed:
10.9.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
25.2.2034Expiry date:
25.2.2026Next due date:
28.2.2026
Title:
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Timeline
Today
26.2.2014EP application
10.6.2020EP Publication
10.9.2020Translation submitted
15.11.2020Registration published
25.2.2026Expires
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10021, US
Inventor
Name:
BRENTJENS, Renier, J.Address:
Short Hills, NJ 07078, US
Name:
JACKSON, Hollie, J.Address:
Hoboken, NJ 07030, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201361769543 PDate:
26.2.2013Country:
US
Classification
Categories:
C12N 5/10, A61K 35/17, A61K 35/545
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 12.1.2021
Expires: 25.2.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2022
Expires: 25.2.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.1.2023
Expires: 25.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.1.2023
Expires: 25.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.1.2023
Expires: 25.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.1.2024
Expires: 25.2.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 16.1.2025
Expires: 25.2.2026
Payer: Árnason Faktor ehf.